INMED PHARMACEUTICALS INC. - Proxy Summary (Nov 2025)

The definitive proxy statement calls for the Annual General and Special Meeting on December 17, 2025 (virtual only).

Key Investor Items:

• Financials: Shareholders will receive audited statements for the fiscal year ended June 30, 2025.
• Board Changes: Board size will reduce to five directors as Bryan Baldasare is not seeking re-election. Five nominees are proposed for election, including two recent appointees (Klompas, Bathery).
• Strategic Funding Approval (Proposal 4): Management seeks approval